DoD Peer Reviewed Cancer, Translational Team Science Award

Application or LOI Due Date
Brief Description

The FY21 PRCRP Translational Team Science Award (TTSA) supports hypothesis-driven translational studies.  These studies must be associated with ongoing or completed clinical trial.  The proposed project should focus on research for the next-phase clinical trial or future clinical application.  The TTSA is intended to support advanced translational studies that are based on results from clinical investigations.  While funding for clinical trials is allowed, the TTSA is intended to support multi-investigator, multidisciplinary teams to perform clinical research studies and not only to fund a clinical trial. Research projects funded by the TTSA should address critical knowledge gaps in clinical outcomes, validate key research results, expand upon potentially game-changing results, or investigate novel clinical findings.  The intent of the TTSA is to utilize information from the clinical trials for research that would then inform the clinic.  The TTSA is not intended to support high-throughput screenings, sequencing.

The goal of the TTSA is to bring together a synergistic team of investigators to interrogate clinical problems and queries that may have an impact on patient outcomes.